EUVIMEDEUVIMED entdecken
Crossref

From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer

Zhenglin He, Hai Tong, Wan Kong, Weiqin Su, Yufei Li, Gensheng Wang, Wen Hu, Liang Qian, Lubin Liu

Oncology Letters · 19.11.2026 · 33 (1) · 1-14

DOI: 10.3892/ol.2026.15957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 19.11.2026. Verfasst von Zhenglin He und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, Z., Tong, H., Kong, W., Su, W., Li, Y., Wang, G., Hu, W., Qian, L., & Liu, L. (2026). From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer. Oncology Letters, 33(1), 1-14. https://doi.org/10.3892/ol.2026.15957

Vancouver

He Z, Tong H, Kong W, Su W, Li Y, Wang G, et al. From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer. Oncology Letters. 2026;33(1):1-14. doi:10.3892/ol.2026.15957

BibTeX
@article{He2026,
  author = {He, Zhenglin and Tong, Hai and Kong, Wan and Su, Weiqin and Li, Yufei and Wang, Gensheng and Hu, Wen and Qian, Liang and Liu, Lubin},
  title = {From genetic susceptibility to malignant epithelial states: An integrated analysis identifies CLPTM1L and USE1 as key genes in high‑grade serous ovarian cancer},
  journal = {Oncology Letters},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--14},
  doi = {10.3892/ol.2026.15957}
}
Kostenlos starten →